BDBM516573 US11053243, Example 159::tert-butyl {(1R)-2-[(2S)-2-({4-[5-({[(2S)-1-{(2R)-2-[(tert-butoxy-carbonyl)amino]-2-phenylacetyl}pyrrolidin-2-yl]carbonyl}amino)-3-(4-methoxyphenyl)-1H-indol-2-yl]phenyl}carbamoyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl}carbamate

SMILES COc1ccc(cc1)-c1c([nH]c2ccc(NC(=O)N3CCCC3C(=O)[C@H](NC(=O)OC(C)(C)C)c3ccccc3)cc12)-c1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@H](NC(=O)OC(C)(C)C)c2ccccc2)cc1

InChI Key

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516573   

TargetGenome polyprotein(Hepatitis C Virus (Virus))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM516573(US11053243, Example 159 | tert-butyl {(1R)-2-[(2S)...)
Affinity DataEC50:  0.00200nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent